Circulating microRNA plasma profile in MuSK+ myasthenia gravis
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 325, 87-91
Abstract
No abstract availableKeywords
Funding Information
- Swedish Research Council (VR-523-2014-2048)
This publication has 27 references indexed in Scilit:
- T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patientsJournal of Autoimmunity, 2014
- Influence of sex differences on microRNA gene regulation in diseaseBiology of Sex Differences, 2014
- Circulating miRNAs in myasthenia gravis: miR‐150‐5p as a new potential biomarkerAnnals of Clinical and Translational Neurology, 2013
- Assessing sample and miRNA profile quality in serum and plasma or other biofluidsMethods, 2013
- Muscle autoantibodies in myasthenia gravis: beyond diagnosis?Expert Review of Clinical Immunology, 2012
- Anti‐musk antibody myasthenia gravis: Clinical findings and response to treatment in two large cohortsMuscle & Nerve, 2011
- Analysis of Circulating MicroRNA: Preanalytical and Analytical ChallengesClinical Chemistry, 2011
- Update on muscle-specific tyrosine kinase antibody positive myasthenia gravisCurrent Opinion in Neurology, 2010
- Racial differences in myasthenia gravis in AlabamaMuscle & Nerve, 2009
- Muscle-Specific Receptor Tyrosine Kinase Antibody Positive Myasthenia Gravis Current StatusJournal of Clinical Neurology, 2009